Free Trial

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 16.66 +0.25 (+1.52%)
(As of 11/21/2024 ET)
No competitors for VanEck Bionic Engineering UCITS ETF A Acc were found.

Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter.

CYBG vs. The Competition

MetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON Exchange
Market Cap£239.06M£250.23M£10.58B£1.41B
Dividend Yield2.25%15.57%10.33%11.56%
P/E Ratio-2.352.1447.721,580.48
Price / Sales0.19116.523,478.81216,422.99
Price / Cash0.130.2430.7133.50
Price / Book0.050.444.122.81
Net IncomeN/A£213M£1.02B£155.39M
7 Day Performance1.13%0.14%0.53%-0.58%
1 Month Performance4.49%0.56%7.78%7.44%
1 Year Performance13.96%2.33%26.43%96.13%

Related Companies and Tools


This page (LON:CYBG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners